Plasma cfDNA Genotyping in Hospitalized Patients With Suspected Metastatic NSCLC

作者: Lynette M. Sholl , Lynette M. Sholl , Biagio Ricciuti , Mark M. Awad , Michael L. Cheng

DOI: 10.1200/PO.21.00029

关键词:

摘要: PURPOSENext-generation sequencing (NGS) is an important component of first-line treatment selection for metastatic non–small-cell lung cancer (NSCLC) and typically ordered by medical oncologists...

参考文章(11)
Regina M. Vidaver, Marianna B. Shershneva, Scott J. Hetzel, Timothy R. Holden, Toby C. Campbell, Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study Journal of Oncology Practice. ,vol. 12, ,(2016) , 10.1200/JOP.2015.009605
Elizabeth P. Garcia, Alissa Minkovsky, Yonghui Jia, Matthew D. Ducar, Priyanka Shivdasani, Xin Gong, Azra H. Ligon, Lynette M. Sholl, Frank C. Kuo, Laura E. MacConaill, Neal I Lindeman, Fei Dong, Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer. Archives of Pathology & Laboratory Medicine. ,vol. 141, pp. 751- 758 ,(2017) , 10.5858/ARPA.2016-0527-OA
Justin I. Odegaard, John J. Vincent, Stefanie Mortimer, James V. Vowles, Bryan C. Ulrich, Kimberly C. Banks, Stephen R. Fairclough, Oliver A. Zill, Marcin Sikora, Reza Mokhtari, Diana Abdueva, Rebecca J. Nagy, Christine E. Lee, Lesli A. Kiedrowski, Cloud P. Paweletz, Helmy Eltoukhy, Richard B. Lanman, Darya I. Chudova, AmirAli Talasaz, Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- And Plasma-Based Methodologies Clinical Cancer Research. ,vol. 24, pp. 3539- 3549 ,(2018) , 10.1158/1078-0432.CCR-17-3831
Charu Aggarwal, Jeffrey C. Thompson, Taylor A. Black, Sharyn I. Katz, Ryan Fan, Stephanie S. Yee, Austin L. Chien, Tracey L. Evans, Joshua M. Bauml, Evan W. Alley, Christine A. Ciunci, Abigail T. Berman, Roger B. Cohen, David B. Lieberman, Krishna S. Majmundar, Samantha L. Savitch, Jennifer J. D. Morrissette, Wei-Ting Hwang, Kojo S. J. Elenitoba-Johnson, Corey J. Langer, Erica L. Carpenter, Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer. JAMA Oncology. ,vol. 5, pp. 173- 180 ,(2019) , 10.1001/JAMAONCOL.2018.4305
Natasha B. Leighl, Ray D. Page, Victoria M. Raymond, Davey B. Daniel, Stephen G. Divers, Karen L. Reckamp, Miguel A. Villalona-Calero, Daniel Dix, Justin I. Odegaard, Richard B. Lanman, Vassiliki A. Papadimitrakopoulou, Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer. Clinical Cancer Research. ,vol. 25, pp. 4691- 4700 ,(2019) , 10.1158/1078-0432.CCR-19-0624
Minetta C Liu, GR Oxnard, EA Klein, CSMCC Swanton, MV Seiden, Minetta C Liu, Geoffrey R Oxnard, Eric A Klein, David Smith, Donald Richards, Timothy J Yeatman, Allen L Cohn, Rosanna Lapham, Jessica Clement, Alexander S Parker, Mohan K Tummala, Kristi McIntyre, Mikkael A Sekeres, Alan H Bryce, Robert Siegel, Xuezhong Wang, David P Cosgrove, Nadeem R Abu-Rustum, Jonathan Trent, David D Thiel, Carlos Becerra, Manish Agrawal, Lawrence E Garbo, Jeffrey K Giguere, Ross M Michels, Ronald P Harris, Stephen L Richey, Timothy A McCarthy, David M Waterhouse, Fergus J Couch, Sharon T Wilks, Amy K Krie, Rama Balaraman, Alvaro Restrepo, Michael W Meshad, Kimberly Rieger-Christ, Travis Sullivan, Christine M Lee, Daniel R Greenwald, William Oh, Che-Kai Tsao, Neil Fleshner, Hagen F Kennecke, Maged F Khalil, David R Spigel, Atisha P Manhas, Brian K Ulrich, Philip A Kovoor, Christopher Stokoe, Jay G Courtright, Habte A Yimer, Timothy G Larson, Charles Swanton, Michael V Seiden, Steven R Cummings, Inc GRAIL, Farnaz Absalan, Gregory Alexander, Brian Allen, Hamed Amini, Alexander M Aravanis, Siddhartha Bagaria, Leila Bazargan, John F Beausang, Jennifer Berman, Craig Betts, Alexander Blocker, Joerg Bredno, Robert Calef, Gordon Cann, Jeremy Carter, Christopher Chang, Hemanshi Chawla, Xiaoji Chen, Tom C Chien, Daniel Civello, Konstantin Davydov, Vasiliki Demas, Mohini Desai, Zhao Dong, Saniya Fayzullina, Alexander P Fields, Darya Filippova, Peter Freese, Eric T Fung, Sante Gnerre, Samuel Gross, Meredith Halks-Miller, Megan P Hall, Anne-Renee Hartman, Chenlu Hou, Earl Hubbell, Nathan Hunkapiller, Karthik Jagadeesh, Arash Jamshidi, Roger Jiang, Byoungsok Jung, TaeHyung Kim, Richard D Klausner, Kathryn N Kurtzman, Mark Lee, Wendy Lin, Jafi Lipson, Hai Liu, Qinwen Liu, Margarita Lopatin, Tara Maddala, M Cyrus Maher, Collin Melton, Andrea Mich, Shivani Nautiyal, Jonathan Newman, Joshua Newman, Virgil Nicula, Cosmos Nicolaou, Ongjen Nikolic, Wenying Pan, Shilpen Patel, Sarah A Prins, Richard Rava, Neda Ronaghi, Onur Sakarya, Ravi Vijaya Satya, Jan Schellenberger, Eric Scott, Amy J Sehnert, Rita Shaknovich, Avinash Shanmugam, KC Shashidhar, Ling Shen, Archana Shenoy, Seyedmehdi Shojaee, Pranav Singh, Kristan K Steffen, Susan Tang, Jonathan M Toung, Anton Valouev, Oliver Venn, Richard T Williams, Tony Wu, Hui H Xu, Christopher Yakym, Xiao Yang, Jessica Yecies, Alexander S Yip, None, Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA Annals of Oncology. ,vol. 31, pp. 745- 759 ,(2020) , 10.1016/J.ANNONC.2020.02.011
Anne Marie Lennon, Adam H. Buchanan, Isaac Kinde, Andrew Warren, Ashley Honushefsky, Ariella T. Cohain, David H. Ledbetter, Fred Sanfilippo, Kathleen Sheridan, Dillenia Rosica, Christian S. Adonizio, Hee Jung Hwang, Kamel Lahouel, Joshua D. Cohen, Christopher Douville, Aalpen A. Patel, Leonardo N. Hagmann, David D. Rolston, Nirav Malani, Shibin Zhou, Chetan Bettegowda, David L. Diehl, Bobbi Urban, Christopher D. Still, Lisa Kann, Julie I. Woods, Zachary M. Salvati, Joseph Vadakara, Rosemary Leeming, Prianka Bhattacharya, Carroll Walter, Alex Parker, Christoph Lengauer, Alison Klein, Cristian Tomasetti, Elliot K. Fishman, Ralph H. Hruban, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention Science. ,vol. 369, ,(2020) , 10.1126/SCIENCE.ABB9601
Justin F. Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe Alexandre Cassier, Gilberto Lopes, Daniel Shao-Weng Tan, Elena Garralda, Luis G. Paz-Ares, Byoung Chul Cho, Shirish M. Gadgeel, Michael Thomas, Stephen V. Liu, Corinne Clifford, Hui Zhang, Christopher D. Turner, Vivek Subbiah, Registrational dataset from the phase I/II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced RET fusion+ non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. ,vol. 38, pp. 9515- 9515 ,(2020) , 10.1200/JCO.2020.38.15_SUPPL.9515
Alexander Drilon, Geoffrey R. Oxnard, Daniel S.W. Tan, Herbert H.F. Loong, Melissa Johnson, Justin Gainor, Caroline E. McCoach, Oliver Gautschi, Benjamin Besse, Byoung C. Cho, Nir Peled, Jared Weiss, Yu-Jung Kim, Yuichiro Ohe, Makoto Nishio, Keunchil Park, Jyoti Patel, Takashi Seto, Tomohiro Sakamoto, Ezra Rosen, Manisha H. Shah, Fabrice Barlesi, Philippe A. Cassier, Lyudmila Bazhenova, Filippo De Braud, Elena Garralda, Vamsidhar Velcheti, Miyako Satouchi, Kadoaki Ohashi, Nathan A. Pennell, Karen L. Reckamp, Grace K. Dy, Jürgen Wolf, Benjamin Solomon, Gerald Falchook, Kevin Ebata, Michele Nguyen, Binoj Nair, Edward Y. Zhu, Luxi Yang, Xin Huang, Elizabeth Olek, S. Michael Rothenberg, Koichi Goto, Vivek Subbiah, Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer. The New England Journal of Medicine. ,vol. 383, pp. 813- 824 ,(2020) , 10.1056/NEJMOA2005653
Jürgen Wolf, Takashi Seto, Ji-Youn Han, Noemi Reguart, Edward B. Garon, Harry J.M. Groen, Daniel S.W. Tan, Toyoaki Hida, Maja de Jonge, Sergey V. Orlov, Egbert F. Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Maximilian Hochmair, Enriqueta Felip, Makoto Nishio, Michael Thomas, Kadoaki Ohashi, Ryo Toyozawa, Tobias R. Overbeck, Filippo de Marinis, Tae-Min Kim, Eckart Laack, Anna Robeva, Sylvie Le Mouhaer, Maeve Waldron-Lynch, Banu Sankaran, O. Alejandro Balbin, Xiaoming Cui, Monica Giovannini, Mikhail Akimov, Rebecca S. Heist, Capmatinib in MET Exon 14–Mutated or MET-Amplified Non–Small-Cell Lung Cancer The New England Journal of Medicine. ,vol. 383, pp. 944- 957 ,(2020) , 10.1056/NEJMOA2002787